Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pathophysiology of Cardiac Performance

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...

Antianginal Drugs: Nitrates and β-Blockers

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development of a broadband hard x-ray radiography platform for pulsed-power experiments.

The Review of scientific instruments·2026

Same author

Tendon transfer surgery for radial nerve palsy.

Hand surgery & rehabilitation·2021

Same author

Correction of ulnar claw hand and Wartenberg's sign.

Hand surgery & rehabilitation·2021

Same author

Blast injury of the hand related to warfare explosive devices: experience from the French Military Health Service.

BMJ military health·2020

Same author

Toward time-resolved laser T-jump/X-ray probe spectroscopy in aqueous solutions.

Structural dynamics (Melville, N.Y.)·2019

Same author

Genetic investigation of equine recurrent uveitis in Appaloosa horses.

Animal genetics·2019

Search research articles

Related Experiment Video

Updated: May 5, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

Effect of mediators on coronary circulation.

G Ertl¹, B Bauer, S Neubauer

¹Medizinische Klinik, Universität Würzburg, Germany.

European Heart Journal

|August 1, 1991

Summary

Vasoactive mediators in the heart and plasma may play a role in inflammatory heart disease. Their specific actions on coronary blood vessels in animal models are reviewed, but human relevance requires further study.

Area of Science:

Cardiovascular Science
Pharmacology
Pathophysiology

Background:

Vasoactive mediators are present in plasma and cardiac tissue.
These mediators may be released during inflammatory heart disease.
Understanding their function is crucial for cardiovascular research.

Purpose of the Study:

To review the action of vasoactive mediators on coronary vasculature.
To explore the potential role of these mediators in inflammatory heart disease.
To highlight areas for future clinical investigation.

Main Methods:

Literature review of studies on vasoactive mediators.
Analysis of data from animal models of cardiovascular conditions.
Synthesis of information on mediator actions and inflammatory processes.

More Related Videos

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Experiment Videos

Last Updated: May 5, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Main Results:

Vasoactive mediators have diverse effects on coronary blood vessels.
Evidence suggests a potential role in animal models of inflammatory heart disease.
Data from human studies are currently limited.

Conclusions:

Vasoactive mediators are implicated in cardiovascular inflammation.
Animal models provide insights into potential mechanisms.
Further research is needed to determine the role of these mediators in human inflammatory heart disease.